Nonablative Fractional 1927‐nm Laser for Periorbital Rejuvenation: A Prospective, Double‐Arm, Open‐Label Trial
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70274 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Chang-Ming Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Rejuvenation, Skin Aging, Lasers, Semiconductor, Low-Level Light Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BRIDGECON CO., LTD.
Abstract (Originalsprache)
Background
The 1927‐nm nonablative fractional laser is widely used for skin rejuvenation and hyperpigmentation. However, its efficacy and safety for periorbital rejuvenation remain uncertain.
Aims
To assess the effects of the 1927‐nm nonablative fractional diode laser on periorbital rejuvenation. Patients/Methods Twenty participants were randomized into two groups and received three treatments at 2‐week (Group A) or 4‐week (Group B) intervals. Clinical efficacy was assessed using ANTERA 3D, blinded investigator‐rated scores, and subject self‐assessments.
Results
Both group A and group B exhibited statistically significant improvements in L* (color measurement which indicates lightness) and pigmentation score at the end‐of‐study visit compared to baseline, with group B also achieving statistically significant enhancement in the pores' index and wrinkles' score. Group B showed greater improvement in wrinkles' score compared to group A at the end‐of‐study visit. The median of Global Aesthetic Improvement Scale assessed by both the physicians and subjects showed improvement, ranging from “improved” to “much improved” at the end‐of‐study visit. Transient side effects including tenderness, erythema, swelling, and scaling were observed, with the majority resolving within 7 days.
Conclusions
The 1927‐nm diode laser is an effective and safe option for periorbital rejuvenation. The 4‐week interval treatment appears to be the preferable option due to its superior improvement in the wrinkles' score at the end of the study. The positive changes in skin brightness and the reduction of brown spots represented additional benefits, setting it apart as a notable alternative to other ablative and nonablative fractional lasers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
- Department of Dermatology, College of Medicine, National Taiwan University, Taipei, Taiwan.
ORCID-Profile: Chang-Ming Huang, Yi-Shuan Sheen
Förderung
- BRIDGECON CO., LTD
Zitieren
APA
Huang, C. M., Sheen, Y. S., & Liao, Y. H. (2025). Nonablative Fractional 1927‐nm Laser for Periorbital Rejuvenation: A Prospective, Double‐Arm, Open‐Label Trial. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70274
Vancouver
Huang CM, Sheen YS, Liao YH. Nonablative Fractional 1927‐nm Laser for Periorbital Rejuvenation: A Prospective, Double‐Arm, Open‐Label Trial. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70274
BibTeX
@article{Huang2025,
author = {Huang, Chang-Ming and Sheen, Yi-Shuan and Liao, Yi-Hua},
title = {Nonablative Fractional 1927‐nm Laser for Periorbital Rejuvenation: A Prospective, Double‐Arm, Open‐Label Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70274}
}
EUVIMED